<DOC>
	<DOCNO>NCT02884115</DOCNO>
	<brief_summary>A continue challenge determine response treatment early syphilis ( primary , secondary , early latent syphilis ) exemplify substantial proportion patient fail achieve serological cure remain serofast . Although retreatment often do clinical practice , optimal management remain uncertain due paucity data regard serological response retreatment long-term outcome . Furthermore , investigator rule gradually increase seroreversion/serological cure rate may due natural decline rapid plasma regain ( RPR ) titers initial therapy , rather due additional dose benzathine penicillin . Thus , investigator would like conduct clinical trial compare serological response rate serofast early syphilis case retreat three dos benzathine penicillin absence retreatment ( control group ) .</brief_summary>
	<brief_title>Serological Response Retreatment Serofast Early Syphilis Cases With Benzathine Penicillin</brief_title>
	<detailed_description />
	<mesh_term>Syphilis</mesh_term>
	<mesh_term>Penicillins</mesh_term>
	<mesh_term>Penicillin G Benzathine</mesh_term>
	<mesh_term>Penicillin G</mesh_term>
	<mesh_term>Penicillin G Procaine</mesh_term>
	<criteria>Early Syphilis Cases Determined Be Serofast 6 Months Initial Treatment Human immunodeficiency virus ( HIV ) infect Baseline serology show nonreactive RPR test followup inadequate Allergic penicillin Pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>